siRNA targeting inner centromere protein antigens (INCENP)
AssigneeDharmacon, Inc.
InventorsAnastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
Life of this patent
Estimating the term…
Abstract
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for INCENP.
Claims20
An siRNA molecule, wherein said siRNA molecule consists of:
- (a) a duplex region;
- and (b) either no overhangs regions or at least one overhang region, wherein each overhang region comprises six or fewer nucleotides, wherein the duplex region consists of a sense region and an antisense region, wherein said sense region and said antisense region together form said duplex region and said duplex region is 19-30 base pairs in length and said antisense region comprises a sequence that is the complement of SEQ ID NO:
- 601.
A chemically synthesized double-stranded siRNA molecule that directs cleavage of mRNA via RNA interference, wherein:
- a. each strand of said siRNA molecule is between 19 and 30 nucleotides in length;
- and
- b. one strand of said siRNA molecule comprises a sequence that is the complement of SEQ ID NO:
- 601.
An siRNA molecule consisting of:
- (a) a duplex region;
- and
- (b) either no overhang regions or at least one overhang region, wherein each overhang region comprises six or fewer nucleotides,
- wherein the duplex region is nineteen base pairs in length and consists of a sense region that has a sequence that is the same as SEQ ID NO:
- 601 and an antisense region that has a sequence that is the complement of SEQ ID NO:
- 601.
Dependencies are inferred from the claim text.